Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes re... Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Health Inc. and changed its name to Grey Matters Health Inc. in April 2026. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.155 | -30.3921568627 | 0.51 | 0.53 | 0.34 | 59965 | 0.37816181 | CS |
| 4 | -0.065 | -15.4761904762 | 0.42 | 0.68 | 0.34 | 31851 | 0.44360418 | CS |
| 12 | -0.175 | -33.0188679245 | 0.53 | 0.68 | 0.335 | 20221 | 0.43095248 | CS |
| 26 | -0.175 | -33.0188679245 | 0.53 | 0.68 | 0.335 | 20221 | 0.43095248 | CS |
| 52 | -0.175 | -33.0188679245 | 0.53 | 0.68 | 0.335 | 20221 | 0.43095248 | CS |
| 156 | -0.175 | -33.0188679245 | 0.53 | 0.68 | 0.335 | 20221 | 0.43095248 | CS |
| 260 | -0.175 | -33.0188679245 | 0.53 | 0.68 | 0.335 | 20221 | 0.43095248 | CS |
mightymite1
30分前
Ray_137
35分前
Steady_T
37分前
ducci1
44分前
Oleblue
46分前
bigstocksnbonds
47分前
3331
52分前
in99flyers
52分前
3331
53分前
Oleblue
53分前
Oleblue
53分前
Oleblue
60分前
Oleblue
60分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。